International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewRafaël Fonseca, Hervé Avet‐Loiseau, W. Michael Kuehl et al.|Leukemia|2009Cited by 877
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working GroupPhilippe Moreau, Jean‐Luc Harousseau, Shaji Kumar et al.|The Lancet Oncology|2021Cited by 266
Ductal Carcinoma in Situ of the BreastRafaël Fonseca, John J. Gisvold, Lynn C. Hartmann et al.|Annals of Internal Medicine|1997Cited by 245
Cevostamab Monotherapy Continues to Show Clinically Meaningful Activity and Manageable Safety in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I StudySuzanne Trudel, Simon J. Harrison, Adam D. Cohen et al.|Blood|2021Cited by 161
Multiple myeloma cells’ capacity to decompose H2O2 determines lenalidomide sensitivitySinto Sebastian, Rafaël Fonseca|Blood|2016Cited by 46